Xiao-Tang Kong

Clinical trials

• Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

  Site PI · Recruiting · Phase 3

  NRG Oncology

  2026–2035
• Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

  Site PI · Recruiting · Phase 3

  Alliance for Clinical Trials in Oncology

  2026–2040
• The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

  Site PI · Recruiting · Phase 2

  University of Utah

  2022–2028
• Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

  Site PI · Recruiting · Phase 3

  NRG Oncology

  2017–2032